N+1 Singer shares its H1 2018 Review

In our H1 review, we discuss the UK economic and equity market environment and notable transactions completed in the first half of 2018.

CEIBA Investments Limited: First day of dealings on the Specialist Fund Segment of the Main Market of the London Stock Exchange

Further to the announcement on 17th October 2018, CEIBA Investments Limited is pleased to announce that trading in its shares commenced at 8.00am today on the Specialist Fund Segment of the Main Market of the London

Read More
N+1 Singer acts as Financial Adviser to April 1983 for the Recommended Cash Offer of Produce Investments

Recommended Cash Offer with Unlisted Partial Share and Loan Note Alternative for Produce Investments PLC by April 1983 Bidco Limited.  On 11th September 2018, the Independent Committee of the Board of Produce Investments PLC and the

Read More
Renalytix AI Plc: Successful fundraising and proposed admission to AIM

EKF Diagnostics Holdings Plc (AIM: EKF), the AIM-traded medical diagnostics business, has recently announced that Renalytix AI Plc, a spin-out from EKF, has conditionally raised gross funds of a minimum of £21 million in connection with

Read More

Transaction Highlights

AVI Japan Opportunity Trust Plc

Date: October 2018

Sector: Investment Funds

Type: Placing


£80.0 million

Summerway Capital Plc

Date: October 2018

Sector: Consumer

Type: IPO


£5.73 million

Futura Medical Plc

Date: October 2018

Sector: Healthcare

Type: Placing, Subscription, Offer for Subscription and Planned Open Offer


£5.6 million

Communications about our events, transactions and industries.